In fact, the findings of previous reports have shown that LRIG1 is downregulated in several types of tumors, such as cutaneous squamous cell carcinoma [24], renal cell carcinoma [25], glioblastoma [26], and breast cancer [27]. This evidence concerns the gene LRIG1 and glioblastoma.